1. Home
  2. RNA vs VERI Comparison

RNA vs VERI Comparison

Compare RNA & VERI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avidity Biosciences Inc.

RNA

Avidity Biosciences Inc.

HOLD

Current Price

$13.08

Market Cap

227.6M

Sector

Health Care

ML Signal

HOLD

Logo Veritone Inc.

VERI

Veritone Inc.

HOLD

Current Price

$2.79

Market Cap

269.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNA
VERI
Founded
2012
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
227.6M
269.0M
IPO Year
2025
2017

Fundamental Metrics

Financial Performance
Metric
RNA
VERI
Price
$13.08
$2.79
Analyst Decision
Buy
Strong Buy
Analyst Count
20
5
Target Price
$69.26
$10.00
AVG Volume (30 Days)
2.1M
1.5M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.36
EPS
N/A
N/A
Revenue
N/A
$92,637,000.00
Revenue This Year
$88.12
$20.56
Revenue Next Year
$18.11
$19.11
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.06
$1.29
52 Week High
$73.06
$9.42

Technical Indicators

Market Signals
Indicator
RNA
VERI
Relative Strength Index (RSI) 5.61 39.03
Support Level $13.06 $2.61
Resistance Level $72.52 $3.19
Average True Range (ATR) 1.05 0.19
MACD -0.24 0.03
Stochastic Oscillator 3.62 23.17

Price Performance

Historical Comparison
RNA
VERI

About RNA Avidity Biosciences Inc.

Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.

About VERI Veritone Inc.

Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has a presence in the United States, the United Kingdom, France, Australia, Israel, and India.

Share on Social Networks: